Literature DB >> 7541948

Cytokine-binding proteins in the lung.

J C Bonner1, A R Brody.   

Abstract

Numerous cytokines and growth factors signal the normal processes of tissue maintenance and remodeling in the lung, yet the aberrant expression of these peptide mediators is involved in a variety of pulmonary diseases. Furthermore, several different binding proteins function in controlling the extracellular levels of many of these cytokines in the lung. For example, a variety of cytokines and growth factors bind to and are regulated by the ubiquitous proteinase inhibitor, alpha 2-macroglobulin. The insulin-like growth factors are controlled by a specific class of six different insulin-like growth factor binding proteins. The transforming growth factor-beta family and fibroblast growth factors interact with extracellular matrix proteins. Several growth factor receptors are shed into the extracellular milieu where they retain a functional binding domain and thereby act as specific binding proteins. Cytokine-binding proteins appear to have a diversity of functions and may serve as extracellular cytokine reservoirs, protective shields against proteolytic degradation of cytokines, modifiers of cytokine-induced biological activity, or as clearance avenues for cytokines. The wide spectrum of cytokine-regulating molecules is important in cell-cell communications under normal conditions, whereas cytokine-binding protein dysfunction could contribute to a number of pulmonary diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541948     DOI: 10.1152/ajplung.1995.268.6.L869

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Regulation of circulating leptin in humans.

Authors:  B Ahrén; H Larsson; C Wilhelmsson; B Näsman; T Olsson
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

Review 2.  Pharmacokinetic studies with recombinant cytokines. Scientific issues and practical considerations.

Authors:  S C Piscitelli; W G Reiss; W D Figg; W P Petros
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

3.  Effect of alpha2-macroglobulin on retinal glial cell proliferation.

Authors:  Ivan Milenkovic; Gerd Birkenmeier; Peter Wiedemann; Andreas Reichenbach; Andreas Bringmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

Review 4.  Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.

Authors:  Brooke T Mossman; Morton Lippmann; Thomas W Hesterberg; Karl T Kelsey; Aaron Barchowsky; James C Bonner
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

5.  Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis.

Authors:  Moises Selman; Annie Pardo; Lourdes Barrera; Andrea Estrada; Susan R Watson; Keith Wilson; Natasha Aziz; Naftali Kaminski; Albert Zlotnik
Journal:  Am J Respir Crit Care Med       Date:  2005-09-15       Impact factor: 21.405

Review 6.  Interstitial fibrosis and growth factors.

Authors:  J A Lasky; A R Brody
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

Review 7.  Microvascular targets for anti-fibrotic therapeutics.

Authors:  Kai-Ming T Pu; Parid Sava; Anjelica L Gonzalez
Journal:  Yale J Biol Med       Date:  2013-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.